Enjoy complimentary customisation on priority with our Enterprise License!
The flow diversion aneurysm treatment market size is estimated to grow by USD 2.43 billion at a CAGR of 9.34% between 2023 and 2028. The market is witnessing significant growth due to the increasing incidence of intracranial aneurysms and the advancements in flow diverter technology. Intracranial aneurysms are a serious condition characterized by the bulging or ballooning of a Blood artery in the brain. These aneurysms can rupture, leading to hemorrhage and potential neurological damage. Flow diverters, a type of endovascular device, have emerged as a promising solution for the treatment of these aneurysms. These devices work by promoting the formation of a blood clot within the aneurysm, thereby reducing the risk of rupture.
Advancements in flow diverter technology have had a profound impact on the market. Innovations such as coil embolization and vessel remodeling with balloons have expanded the applications of flow diversion, improved patient outcomes, and driven market growth. The treatment of a broad range of types of aneurysms was made possible by improved flow diversion designs, e.g. reduced profile devices, dual layer flow diverters, and braided/laser-cut devices. These advancements have expanded the pool of patients eligible for flow diversion, leading to increased demand for this mode of treatment.
To learn more about this report, Download Report Sample
FDS
The market share growth by the FDS segment will be significant during the forecast period. Flow-diverting stents, also known as flow diverters, are specialized medical devices used in the treatment of certain brain vascular conditions, specifically complex and wide-necked intracranial aneurysms. These stents are intended to redirect blood flow from the aneurysm, thereby helping create a blood clot in an aneurysm, ultimately leading to its healing and occlusion.
Get a glance at the market contribution of various segments Download PDF Sample
The FDS segment was valued at USD 2.90 billion in 2018. Flow-diverting stents offer several benefits as a treatment option for certain complex and wide-necked intracranial aneurysms. They are not suited to all cases but may offer significant advantages in comparison with traditional treatment methods such as surgical clipping when appropriately selected and used. The applications of FDS will contribute to the growth of the FDS segment, which in turn will propel the market to focus during the forecast period.
Hospitals
Flow diversion has found significant application in hospitals as an effective and less invasive treatment option for certain intracranial aneurysms. Flow diversion is particularly useful for treating complex, wide-necked, and large aneurysms that are difficult to manage with traditional endovascular coiling or surgical clipping. These aneurysms are more likely to rupture and may be located in focal areas of the brain, which make them difficult to treat with other methods. In hospitals, patients are spending fewer hours and thus reducing healthcare costs and freeing up hospital resources for other patients. Thus, these applications of flow diversion aneurysm treatment will contribute to the growth of the hospital segment, which will propel the growth of the market in focus during the forecast period.
Specialty clinics
Flow diversion for treating intracranial aneurysms is primarily performed in specialized neuro-interventional or neurovascular clinics. These specialty clinics have the expertise, advanced equipment, and experienced medical professionals needed to perform flow diversion procedures effectively and safely. Neuro-interventionalists or interventional neuroradiologists with a high degree of expertise in performing endovascular brain and spinal procedures are available at specialized clinics that provide flow diversion therapy. Specialty clinics are equipped with state-of-the-art endovascular method suites where flow diversion and other endovascular treatments are performed. These suites have advanced fluoroscopy and imaging equipment necessary for guiding catheters and flow diverter deployment.
For more insights about the market share of various regions Download PDF Sample now!
North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period.
North America accounts for a significant share of the market. The United States and Canada hold the majority of market shares in this region. The rapid growth of the market in this region is attributed to high awareness about impacts and treatment procedures for aneurysms, the increasing number of flow diversion procedures being performed, improved healthcare infrastructure, and increased healthcare expenditure.
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:
Acandis GmbH: The company offers ACCERO Stent and ACCLINO flex plus Stent for the treatment of Flow Diversion Aneurysms.
Acandis GmbH, BALT Group, Cardinal Health Inc., Endologix LLC, Evasc Medical Systems Corp., Imperative Care Inc., InNeuroCo, Inspire MD Inc., Johnson and Johnson Services Inc., Lepu Medical Technology Beijing Co. Ltd., Medtronic Plc, Merlin MD Pte. Ltd., MicroPort Scientific Corp., Oxford Endovascular Ltd., Penumbra Inc., Rapid Medical Ltd., Siemens AG, Stryker Corp., Terumo Corp., and Wallby Medical LLC
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market is witnessing significant growth, driven by advancements in endovascular techniques and neurointerventional procedures for treating brain aneurysms. This therapeutic approach offers a minimally invasive alternative to traditional surgical interventions, particularly for ruptured aneurysms and those in the posterior circulation or distal anterior circulation. Flow diversion devices such as the Silk flow diverter, Pipeline embolization device, and Surpass flow diverter are revolutionizing minimally invasive endovascular surgeries, facilitating aneurysm occlusion with precision. With the global aging demographic and increasing demand for specialized neurointerventional care, the market addresses the healthcare burden by providing minimally invasive healthcare options. Skilled neurointerventionalists leverage their expertise in cerebral anatomy to deliver effective treatments, underscoring the importance of minimally invasive treatment in improving patient outcomes. Our researchers analyzed the market research and growth data with 2023 as the base year, along with the key market growth analysis, trends, and challenges. A holistic analysis of drivers, trends, and challenges will help companies refine their marketing strategies to gain a competitive advantage.
The increasing Incidence of intracranial aneurysms is a growing driver in the market. A significant driving factor for growth in the flow diversion aneurysm therapy market is an increasing incidence of intracranial aneurysms. The growing prevalence of intracranial aneurysms is driving the demand for effective and advanced treatment options. Flow diversion has emerged as a valuable treatment modality, especially for managing complex and large aneurysms that may be challenging to treat with traditional methods.
However, as the global population continues to age, the incidence of aneurysms is likely to increase, and the demand for flow diversion and other treatment options is increasing. An increase in the number of people vulnerable to aneurysms is anticipated to drive the growth of the market during the forecast period.
The expanding indications of flow diversion procedures are a key trend in the market. The use of flow diversion aneurysm treatment methods has significantly impacted the aneurysm treatment market due to expanded indications. As the medical community continues to study and confirm the effectiveness of flow diversion in treating various intracranial aneurysms, the demand for flow diverters and associated medical services has risen.
With the broadening of indications, more patients with diverse types of intracranial aneurysms are becoming eligible candidates for flow diversion treatment. Due to increasing evidence, healthcare providers are more likely to offer flow diversion as a treatment option for various types of aneurysms. Due to expanded indications, the demand for flow diversion procedures has increased, which, in turn, is driving the growth of the market in focus during the forecast period.
The higher cost of flow diverter devices is a major challenge faced by the market. The cost of treating an aneurysm with flow diversion varies widely depending on factors such as location, aneurysm complexity, flow diverter type, medical facility, and additional medical services needed.
Flow diverters are specialized medical devices made of advanced materials, and they can be relatively expensive. The duration of hospital stay after the flow diversion procedure depends on the patient's condition and hospital policies, with longer stays resulting in higher costs. The high costs associated with flow diverter devices will hamper the growth of the market in focus during the forecast period.
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Customer Landscape
The market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD Million" for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.
Neurovascular Devices Market: Neurovascular Devices Market by Product and Geography - Forecast and Analysis
Aneurysm Coiling and Embolization Devices Market: Aneurysm Coiling and Embolization Devices Market by Product and Geography - Forecast and Analysis
Endovascular Abdominal Aortic Aneurysm (AAA) Repair Devices Market: Endovascular Abdominal Aortic Aneurysm (AAA) Repair Devices Market by End-user, Product, and Geography - Forecast and Analysis
The market is witnessing remarkable growth, driven by advancements in endovascular technique for treating brain aneurysm. This therapeutic method targets cerebral aneurysms located in both posterior circulation aneurysms and distal anterior circulation aneurysms, offering a minimally invasive treatment approach that reduces post-operative complications and improves patient outcomes.
Furthermore, endovascular treatment utilizes Flow Diverting Stents (FDS) to redirect blood flow away from the parent blood vessel, promoting aneurysm occlusion while minimizing mortality rates and hospital fees, and Physician charges. Access to specialized training ensures skilled interventionists can navigate neuroimaging technologies and various imaging modalities effectively. With a focus on patient access and minimally invasive healthcare trends, the market continues to evolve, emphasizing the importance of post-procedure care and ongoing medical research in enhancing treatment efficacy at stroke centers and emergency care facilities equipped with state-of-the-art operating rooms and intensive care units.
Market Scope |
|
Report Coverage |
Details |
Page number |
166 |
Base year |
2023 |
Historic period |
2018 - 2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 9.34% |
Market Growth 2024-2028 |
USD 2.43 billion |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
8.33 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 38% |
Key countries |
US, UK, Germany, Canada, and China |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
Acandis GmbH, BALT Group, Cardinal Health Inc., Endologix LLC, Evasc Medical Systems Corp., Imperative Care Inc., InNeuroCo, Inspire MD Inc., Johnson and Johnson Services Inc., Lepu Medical Technology Beijing Co. Ltd., Medtronic Plc, Merlin MD Pte. Ltd., MicroPort Scientific Corp., Oxford Endovascular Ltd., Penumbra Inc., Rapid Medical Ltd., Siemens AG, Stryker Corp., Terumo Corp., and Wallby Medical LLC |
Market dynamics |
Parent market analysis, Market Forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the market forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download Sample PDF at your Fingertips
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.